Publicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria de Navarra (80)

2023

  1. Antagonic effect of ghrelin and LEAP-2 on hepatic stellate cell activation and liver fibrosis in obesity-associated nonalcoholic fatty liver disease

    European journal of endocrinology, Vol. 188, Núm. 7, pp. 564-577

  2. Antidiabetic Drugs That Reduce Weight and Are Cardioprotective

    Handbook of Obesity - Volume 2: Clinical Applications, Fifth Edition (CRC Press), pp. 318-332

  3. BMI-based obesity classification misses children and adolescents with raised cardiometabolic risk due to increased adiposity

    Cardiovascular Diabetology, Vol. 22, Núm. 1

  4. Corrigendum: Increased levels of interleukin-36 in obesity and type 2 diabetes fuels adipose tissue inflammation by inducing its own expression and release by adipocytes and macrophages(Front. Immunol., (2022), 13, (832185), 10.3389/fimmu.2022.832185)

    Frontiers in Immunology

  5. Effect of guanylin peptides on pancreas steatosis and function in experimental diet-induced obesity and after bariatric surgery

    Frontiers in Endocrinology, Vol. 14

  6. Evaluation of Dietary and Alcohol Drinking Patterns in Patients with Excess Body Weight in a Spanish Cohort: Impact on Cardiometabolic Risk Factors

    Nutrients, Vol. 15, Núm. 22

  7. Increased Aquaporin-7 Expression Is Associated with Changes in Rat Brown Adipose Tissue Whitening in Obesity: Impact of Cold Exposure and Bariatric Surgery

    International Journal of Molecular Sciences, Vol. 24, Núm. 4

  8. Increased Expression Levels of Netrin-1 in Visceral Adipose Tissue during Obesity Favour Colon Cancer Cell Migration

    Cancers, Vol. 15, Núm. 4

  9. Molecular and cellular mechanisms underlying the hepatoprotective role of ghrelin against NAFLD progression

    Journal of Physiology and Biochemistry, Vol. 79, Núm. 4, pp. 833-849

  10. Peptide Polyagonists for the Treatment of Nonalcoholic Fatty Liver Disease

    Current Pharmaceutical Design

  11. Phenotyping the obesities: reality or utopia?

    Reviews in Endocrine and Metabolic Disorders, Vol. 24, Núm. 5, pp. 767-773

  12. Precision nutrition in the context of bariatric surgery

    Reviews in Endocrine and Metabolic Disorders, Vol. 24, Núm. 5, pp. 979-991

  13. Relevance of body composition in phenotyping the obesities

    Reviews in Endocrine and Metabolic Disorders, Vol. 24, Núm. 5, pp. 809-823

  14. Sex- and Age-Dependent Changes in the Adiponectin/Leptin Ratio in Experimental Diet-Induced Obesity in Mice

    Nutrients, Vol. 15, Núm. 1